Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News GNI Group to halt enrolment in Phase 2 liver fibrosis trial following positive results Japanese biotech company GNI Group has announced it will cease enrolment of new patients in its Phase 2… bypharmanewsdailyOctober 2, 2018
